Robert Wood Johnson Medical School Obstetrics and Gynecology

Topics

• Menopause: Health Impacts and Treatments 46
• Sexual function and dysfunction studies 36
• Pelvic floor disorders treatments 33
• Preterm Birth and Chorioamnionitis 32
• Maternal and fetal healthcare 30
• Pregnancy and preeclampsia studies 28
• Reproductive Health and Contraception 28
• Uterine Myomas and Treatments 26
• COVID-19 Impact on Reproduction 25
• Prenatal Screening and Diagnostics 24
• Ovarian cancer diagnosis and treatment 18
• Assisted Reproductive Technology and Twin Pregnancy 17

Most cited

1. Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer.

   The New England journal of medicine · 2023 · 633 citations · Eugenia Girda

2. The genetic basis of endometriosis and comorbidity with other pain and inflammatory conditions.

   Nature genetics · 2023 · 224 citations · Jessica Opoku-Anane

3. Real-world application of tumor mutational burden-high (TMB-high) and microsatellite instability (MSI) confirms their utility as immunotherapy biomarkers.

   ESMO open · 2022 · 289 citations · Aliza Leiser, Eugenia Girda

4. Vasa previa in singleton pregnancies: diagnosis and clinical management based on an international expert consensus.

   American journal of obstetrics and gynecology · 2024 · 39 citations · Ashley Roman

5. Pembrolizumab plus chemotherapy in advanced or recurrent endometrial cancer: overall survival and exploratory analyses of the NRG GY018 phase 3 randomized trial.

   Nature medicine · 2025 · 59 citations · Eugenia Girda

6. Relacorilant and nab-paclitaxel in patients with platinum-resistant ovarian cancer (ROSELLA): an open-label, randomised, controlled, phase 3 trial.

   Lancet (London, England) · 2025 · 49 citations ·